Founded in 1999, Shengtai Pharmaceutical, Inc., ( OTC BB: SGTI) through its wholly owned subsidiary, is a leading domestic producer of pharmaceutical-grade glucose in China. The company has about 40% of the market and one of the only 3 licensed Dextrose Monohydrate manufacturers in China. With increased production capacity ready, the company will have potential to acquire 50% China pharmaceutical glucose market in about 1-2 years. The Company has a great growth revenue in the past several years. The company抯 products include pharmaceutical-grade glucose or dextrose, used for medical purposes as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The company抯 main customers include medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies covering all of China with the exception of Tibet. The Company also export its products to more than 70 different countries.

* Market leader and preferred supplier with more than 40% and increasing market share in China.

* Located in Weifang, Shandong Province, which is the second largest corn producing province in China.

* Low cost labor

* Most competitive capacity ready

* One of the only 3 licensed Dextrose Monohydrate manufacturers in China

* High product quality

* Solid existing customer base

* Extensive distribution network

* Vertically Integrated